ClinicalTrials.Veeva

Menu

Evaluation of the Strategy of "One-stop" Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease

C

Chinese Academy of Medical Sciences, Fuwai Hospital

Status and phase

Unknown
Phase 4

Conditions

Coronary Artery Disease
Aortic Atherosclerotic Disease

Treatments

Procedure: One-stop strategy group

Study type

Interventional

Funder types

Other

Identifiers

NCT03563768
2018-2-4032

Details and patient eligibility

About

The study is a prospective, randomized, controlled, exploratory trail to evaluate the strategy of "one-stop" endovascular treatment for concomitant coronary artery disease and aortic atherosclerotic disease.

Full description

60 patients will be allocated randomly in a 1:1 ratio into one-stop strategy group or staging strategy group. In one-stop strategy group, percutaneous coronary intervention (PCI) will be performed on the same operating room immediately after the endovascular aortic repair (EVAR); In staging strategy group, PCI will be performed several days after EVAR. The safety and effectiveness will be assessed between two groups 1 year after the operation. The economic index will be evaluated as well as.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged from 18 years to 75years, male or female;
  • Aortic atherosclerotic disease with indication of EVAR;
  • Coronary heart disease with indication of PCI;
  • Provided informed consent.

Exclusion criteria

  • Acute aortic dissection
  • Acute coronary syndrome
  • Dysfunction of coagulation system
  • Patients with gastrointestinal hemorrhage
  • Known allergy to contrasts or antiplatelet drugs
  • Renal dysfunction (GFR≤60ml/min)
  • Patient with multi-branch coronary preferred CABG

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

One-stop strategy group
Experimental group
Description:
Percutaneous coronary intervention (PCI) will be performed on the same operating table immediately after the endovascular aortic repair (EVAR)
Treatment:
Procedure: One-stop strategy group
Staging strategy group
No Intervention group
Description:
PCI will be performed several days after EVAR

Trial contacts and locations

1

Loading...

Central trial contact

Kuo Zhang, MD, PhD; Min Yang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems